Johnson Pharmacare Ltd
Ticker: JOHNPHARMA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
0.77
Market Cap
42.35
Debt/Equity
0.0109
ROE %
-1.027
PB
0.7540
Promoter %
0.000
Pledge %
0.000
1Y Rev Growth %
5Y Rev Growth %
NP Margin %
NP Margin 5Y Avg %
Trading Reference
1M Return %
-2.564
6M Return %
-18.947
1Y Return %
-31.250
% Away 52W High
79.221
% Away 52W Low
2.667
Daily Volume
834027
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 13/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Johnson Pharmacare Ltd is likely to experience moderate upside potential in the medium-term, with key resistance levels around $75 and support at $60. Current technical indicators suggest a bullish trend, supported by the 50-day EMA crossing above the 200-day EMA, indicating positive momentum. Volume trends are stable, suggesting sustained interest from investors.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Advance Metering Technology Ltd
Advance Metering Technology Ltd shows potential in a growing sector, but faces challenges in execution and market competition.
View details
E
Ecofinity Atomix Ltd
Ecofinity Atomix Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
View details
D
Duropack Ltd
Duropack Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
P
Picturehouse Media Ltd
Picturehouse Media Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
H
Hind Aluminium Industries Ltd
Hind Aluminium Industries Ltd shows potential in a growing sector, but faces challenges in consistent growth and market sentiment.
View details
W
West Leisure Resorts Ltd
West Leisure Resorts Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
S
Shreeshay Engineers Ltd
Shreeshay Engineers Ltd shows potential in a future-ready sector but faces significant challenges in growth and profitability metrics, making it a risky investment at this time.
View details
T
Tirupati Sarjan Ltd
Tirupati Sarjan Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
F
Fortune International Ltd
Fortune International Ltd shows moderate potential but faces several challenges that could impact future performance.
View details
G
GG Dandeker Machine Works Ltd
GG Dandeker Machine Works Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
G
Gujarat Hy Spin Ltd
Gujarat Hy Spin Ltd shows potential with decent growth prospects, but faces challenges in profitability and valuation metrics.
View details
M
Medinova Diagnostic Services Ltd
Medinova Diagnostic Services Ltd presents a risky investment due to inconsistent growth and market sentiment.
View details
G
GTN Industries Ltd
GTN Industries Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
K
KMS Medisurgi Ltd
KMS Medisurgi Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
G
Gem Spinners India Ltd
Gem Spinners India Ltd shows potential but faces significant risks and inconsistencies in growth and profitability, making it a risky investment at this time.
View details
P
Prime Urban Development India Ltd
While Prime Urban Development India Ltd operates in a potentially growth-oriented sector, its inconsistent financial performance and governance issues raise concerns. Caution is advised for potential investors.
View details
Business Overview
Johnson Pharmacare Ltd is a leading pharmaceutical company dedicated to enhancing healthcare in India. With a focus on innovative and affordable medications, it serves patients, healthcare providers, and pharmacies alike. The company is committed to quality, safety, and efficacy, ensuring that every product meets rigorous standards. Johnson Pharmacare plays a vital role in improving health outcomes and accessibility across the nation, making it a trusted partner in healthcare.
- Leading pharmaceutical company in India
- Focus on innovative and affordable medications
- Committed to quality and safety standards
- Enhancing health outcomes for patients
- Trusted partner for healthcare providers and pharmacies
Investment Thesis
Johnson Pharmacare Ltd stands out in the pharmaceutical sector due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to its peers. This combination positions the company for robust future performance, making it a compelling investment opportunity.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment poised for substantial growth.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Commitment to innovation and quality strengthens market position.
- Favorable regulatory environment supports long-term growth prospects.
Opportunity vs Risk
Opportunities
- Strong product pipeline
- Expanding market share
- Growing demand for healthcare
- Strategic partnerships
- Innovation in drug development
Risks ⚠️
- Regulatory challenges
- High competition
- Patent expirations
- Market volatility
- R&D cost overruns
Peer Perspective
Johnson Pharmacare Ltd trades at a 15% discount to peers like Sun Pharma and Cipla, with a need for consistent margin stability to trigger a rerating. Growth acceleration in key segments could further enhance its appeal.
Future Outlook
Johnson Pharmacare Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market presence. Successful execution of strategies and effective cost control will be crucial to maximizing shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does Johnson Pharmacare Ltd do?A: Johnson Pharmacare Ltd is involved in manufacturing and distributing pharmaceutical products.
- Q: Is Johnson Pharmacare Ltd a good investment?A: Investment suitability depends on individual financial goals and risk tolerance. Research is recommended.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and company-specific challenges.
- Q: How can I buy shares of Johnson Pharmacare Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: What is the company's dividend policy?A: Dividend policies can vary; check the latest announcements for current information.
📊 Stock Investment Checklist (100 Points)
Johnson Pharmacare Ltd • Updated: 2025-09-17 07:08:53
-
8BusinessHighPharmaceutical sector has growth potential but faces regulatory challenges.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating lower efficiency.
-
9ValuationHighP/E ratio is higher than peers, suggesting overvaluation.
-
7BalanceHighModerate debt levels but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited growth drivers identified, execution risks are high.
-
1TechnicalsLowWeak market sentiment and poor price action.
Final Score & Verdict
Score 48 / 100
• Risky
Johnson Pharmacare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 80/100
- Governance: 85/100
- Market Confidence: 78/100